Company Filing History:
Years Active: 2025
Title: Innovations in Cancer Treatment by Nicholas Allan Botwood
Introduction
Nicholas Allan Botwood is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of cancer treatment, particularly in the area of non-small cell lung cancer (NSCLC). His innovative approach combines chemotherapy with targeted immunotherapy, showcasing his commitment to advancing medical science.
Latest Patents
Nicholas Allan Botwood holds a patent titled "Methods of treating NSCLC comprising administering platinum doublet chemotherapy followed by an anti-PD-1 antibody and an anti-CTLA-4 antibody." This patent outlines a method for treating subjects afflicted with tumors derived from NSCLC. The method involves administering a combination of chemotherapy, an anti-PD-1 antibody or an anti-PD-L1 antibody, and an anti-CTLA-4 antibody. Notably, the chemotherapy is administered for a period shorter than the standard treatment duration. This innovative approach aims to enhance the effectiveness of cancer treatment while minimizing the duration of chemotherapy.
Career Highlights
Nicholas Allan Botwood is associated with Bristol-Myers Squibb Company, a leading biopharmaceutical company known for its focus on innovative medicines. His work at the company has allowed him to contribute to groundbreaking research and development in cancer therapies. With a patent portfolio that includes 1 patent, he has established himself as a key figure in the field of oncology.
Collaborations
Throughout his career, Nicholas has collaborated with esteemed colleagues, including Sabine Maier and Abderrahim Oukessou. These collaborations have fostered a dynamic exchange of ideas and expertise, further enhancing the impact of their collective work in cancer treatment.
Conclusion
Nicholas Allan Botwood's contributions to cancer treatment through his innovative patent demonstrate his dedication to improving patient outcomes. His work at Bristol-Myers Squibb Company and collaborations with fellow researchers highlight the importance of teamwork in advancing medical science. His efforts continue to pave the way for more effective cancer therapies.